PE20001361A1 - COMPOSITIONS OBTAINED FROM HOSE INDICA L - Google Patents
COMPOSITIONS OBTAINED FROM HOSE INDICA LInfo
- Publication number
- PE20001361A1 PE20001361A1 PE1999001343A PE00134399A PE20001361A1 PE 20001361 A1 PE20001361 A1 PE 20001361A1 PE 1999001343 A PE1999001343 A PE 1999001343A PE 00134399 A PE00134399 A PE 00134399A PE 20001361 A1 PE20001361 A1 PE 20001361A1
- Authority
- PE
- Peru
- Prior art keywords
- hose
- indica
- compositions obtained
- composition
- pentadecilphenol
- Prior art date
Links
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
SE REFIERE A UNA COMPOSICION OBTENIDA A PARTIR DE UNA MEZCLA DE MANGIFERA INDICAN L; QUE COMPRENDE: a)20%-60% DE POLIFENOLES TAL COMO DE 10%-20% DE MANGIFERINA, 5%-10% DE PENTADECILFENOL, 5%-10% OCTILFENOL, 10%-20% DE AMENTOFLAVONA; b)10%-40% DE TERPENOIDES TAL COMO 15%-30% DE ACIDO MANGIFERONICO, 5%-10% DE BETA-ELEMENO, 5%-10% ALFAGUANIDENO, ENTRE OTROS; c)5%-15% DE ESTEROIDES TAL COMO 2%-8% GAMMA-SITOESTEROL, 1%-5% DE BETASITOESTEROL, 1%-5% DE CAMPESTEROL, ENTRE OTROS; d)1%-5% DE ACIDOS GRASOS TAL COMO 0,1%-3% DE MIRISTICO, 35%-45% DE LINOLEICO, 20%-40% DE OLEICO, 0,1%-1% DE ESTEARICO, ENTRE OTROS; e)1%-3% DE MICROELEMENTOS TAL COMO 0,8%-1,0% DE POTASIO, 0,2%-0,4% DE CALCIO, 0,1%-0,2% DE MAGNESIO, ENTRE OTROS; f)EXCIPIENTES APROPIADO PARA FORMAR UNA TABLETA REVESTIDA, SUSPENSION SABORIZADA, CREMA HIDROFILICA, UNGUENTO TAL COMO RELLENOS, AGLUTINANTES, DESINTEGRANTES, LUBRICANTES ENTRE OTROS. LA COMPOSICION PUEDE SER UTILIZADA PARA PREVENIR EL ENVEJECIMIENTO, ENFERMEDADES DEGENERATIVAS, NEOPLASIAS, QUIMIOPREVENTIVOS, SUPLEMENTO DIETETICOREFERS TO A COMPOSITION OBTAINED FROM A MIX OF HOSE INDICAN L; WHICH INCLUDES: a) 20% -60% OF POLYPHENOLS SUCH AS 10% -20% OF MANGIFERIN, 5% -10% OF PENTADECILPHENOL, 5% -10% OCTILPHENOL, 10% -20% OF AMENTOFLAVONE; b) 10% -40% OF TERPENOIDS SUCH AS 15% -30% OF MANGIFERONIC ACID, 5% -10% OF BETA-ELEMEN, 5% -10% ALPHAGUANIDEN, AMONG OTHERS; c) 5% -15% OF STEROIDS SUCH AS 2% -8% GAMMA-SITOESTEROL, 1% -5% OF BETASITOESTEROL, 1% -5% OF CAMPESTEROL, AMONG OTHERS; d) 1% -5% OF FATTY ACIDS SUCH AS 0.1% -3% OF MIRISTICO, 35% -45% OF LINOLEIC, 20% -40% OF OLEIC, 0.1% -1% OF STEARIC, AMONG OTHERS ; e) 1% -3% OF MICROELEMENTS SUCH AS 0.8% -1.0% OF POTASSIUM, 0.2% -0.4% OF CALCIUM, 0.1% -0.2% OF MAGNESIUM, AMONG OTHERS; f) APPROPRIATE EXCIPIENTS TO FORM A COATED TABLET, FLAVORED SUSPENSION, HYDROPHILIC CREAM, UNGUENT SUCH AS FILLERS, BINDERS, DISINTEGRANTS, LUBRICANTS AMONG OTHERS. THE COMPOSITION CAN BE USED TO PREVENT AGING, DEGENERATIVE DISEASES, NEOPLASIES, CHEMOPREVENTIVES, DIETARY SUPPLEMENT
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20398 | 1998-12-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20001361A1 true PE20001361A1 (en) | 2000-11-19 |
Family
ID=46799448
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1999001343A PE20001361A1 (en) | 1998-12-29 | 1999-12-29 | COMPOSITIONS OBTAINED FROM HOSE INDICA L |
Country Status (1)
| Country | Link |
|---|---|
| PE (1) | PE20001361A1 (en) |
-
1999
- 1999-12-29 PE PE1999001343A patent/PE20001361A1/en not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA102477C2 (en) | Capsule composition | |
| ATE305810T1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING FATTY ACID WHICH IS AT LEAST 80 Wt. CONTAINS EPA AND DHA | |
| IN2000KO00319A (en) | ||
| HUP0301107A2 (en) | Therapeutic combinations of fatty acids and their use | |
| HUP0200111A2 (en) | Use of essential fatty acids for preparation of pharmaceutical composition available in the prevention of cardiovascular events | |
| JPH04507418A (en) | drug formulation | |
| AR022008A1 (en) | A COMPOSITION OF CONTROLLED GALANTAMINE RELEASE, A PROCESS FOR THE PREPARATION OF THE SAME, AND THE USE OF SUCH COMPOSITION FOR THE PREPARATION OF A MEDICINAL PRODUCT | |
| TW429145B (en) | Pharmaceutical composition for treating schizophrenia, tardive dyskinesia, depression, and alzheimer's disease comprising EPA/SA | |
| GB2358631B (en) | Improvements in or relating to conjugated fatty acids and related compounds | |
| MX9606501A (en) | Antifungal-wound healing compositions and methods for preparing and using same. | |
| BR0009373A (en) | Oral pharmaceutical compositions containing long-chain triglycerides and lipophilic surfactants | |
| DE69935995D1 (en) | POLYUNGATURATED FATTY ACIDS NUTRITIONAL SUPPLEMENT | |
| WO2003043972A3 (en) | Functional acylglycerides | |
| RS20100077A (en) | Pharamceutically active uridine esters | |
| HK1084015A1 (en) | Stable pharmaceutical compositions of 2-aza-bicyclo3.3.0 -octane-3- carboxylic acid derivatives 2- | |
| EP1645617B1 (en) | Antioxidant fat or oil composition containing long-chain highly unsaturated fatty acid | |
| US10744082B2 (en) | Compositions for treatment of xerostomia and for tooth treatment | |
| WO2001077271A3 (en) | Conjugated linoleic acid compositions | |
| PE20001361A1 (en) | COMPOSITIONS OBTAINED FROM HOSE INDICA L | |
| WO2002043662A3 (en) | Dietary composition containing conjugated linoleic acid and calcium for improved health | |
| TH60770A (en) | Fatty acid aggregates for therapeutic use | |
| MY130474A (en) | Oral pharmaceutical compositions containing long-chain triglycerides and lipophilic surfactants | |
| BG104673A (en) | Solid pharmaceutical compositions containing miltefosine for oral administration in the treatment of leishmaniasis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |